Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
Kuhan KunarajahStefanie HennigRoss L G NorrisMichael LobbBruce G CharlesRoss PinkertonAndrew S MoorePublished in: Cancer chemotherapy and pharmacology (2017)
Prior anthracycline exposure increased baseline cTnI in a dose-dependent manner, consistent with the known cumulative risk of anthracycline exposure-induced cardiotoxicity.